Apoptosis by death factor

Cell

Volumn 88, Issue 3, 1997, Pages 355-365

  Nagata, Shigekazu ^a,b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CERAMIDE; CYTOKINE; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PHOSPHOTRANSFERASE; PROTEIN BCL 2; SPHINGOMYELIN PHOSPHODIESTERASE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CAENORHABDITIS ELEGANS; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; GENE MUTATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN TERTIARY STRUCTURE; REVIEW;

CAENORHABDITIS ELEGANS;

EID: 0030892234     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81874-7     Document Type: Review

References (85)

1. Adachi, M., Suematsu, S., Kondo, T., Ogasawara, J., Tanaka, T., Yoshida, N., and Nagata, S. (1995). Targeted mutation in the Fas gene causes hyperplasia in the peripheral lymphoid organs and liver. Nature Genet. 11, 294-300.
2. Alnemri, E.S., Livingston, D.J., Nicholson, D.W., Salvesen, G., Thornberry, N.A., Wong, W.W., and Yuan, J. (1996). Human ICE/ CED-3 protease nomenclature. Cell 87, 171.
3. Androlewicz, M.J., Browning, J.L, and Ware, C.F. (1992). Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J. Biol. Chem. 267, 2542-2547.
4. Banner, D.W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.-J., Broger, C., Loetscher, H., and Lesslauer, W. (1993). Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implication for TNF receptor activation. Cell 73, 431-445.
5. Beg, A.A., and Baltimore, D. (1996). An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784.
6. Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., and Duke, R.C. (1995). A role for CD95 ligand in preventing graft rejection. Nature 377, 630-632.
7. Boise, L.H., Minn, A.J., Noel, P.J., June, C.H., Accavitti, M.A., Lindsten, T., and Thompson, C.B. (1995). CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 3, 87-98.
8. Boldin, M.P., Varfolomeev, E.E.,Pancer, Z.,Mett, I.L., Camonis, J.H., and Wallach, D. (1995). A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
9. Boldin, M.P., Goncharov,T.M., Goltsev,Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 85, 803-815.
10. Braun, M.Y., Lowin, B., French, L., Acha-Orbea, H., and Tschopp, J. (1996). Cytotoxic T cells deficient in both functional Fas ligand and perforim show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183, 657-661.
11. Brojatsch, J., Naughton, J., Rolls, M.M., Zingler, K., and Young, J.A.T. (1996). CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 87, 845-855.
12. Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
13. Chinnaiyan, A.M., O'Rourke, K., Yu, G.-L., Lyons, R.H., Garg, M., Duan, R.D., Xing, L., Gentz, R., Ni, J., and Dixit, V.M. (1996). Signal transduction by DR-3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990-992.
14. Cohen, P.L., and Eisenberg, R.A. (1991). Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243-269.
15. Darmon, A.J., Nicholson, D.W., and Bleackley, R.C. (1995). Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377, 446-448.
16. Duan, H., and Dixit, V.M. (1997). RAIDD, a novel death adaptor molecule. Nature 385, 86-89.
17. Ellis, R.E., Yuan, J., and Horvitz, H.R. (1991). Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663-698.
18. Enari, M., Hase, A., and Nagata, S. (1995a). Apoptosis by a cytosolic extract from Fas-activated cells. EMBO J. 14, 5201-5208.
19. Enari, M., Hug, H., and Nagata, S. (1995b). Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78-81.
20. Enari, M., Talanian, R.V., Wong, W.W., and Nagata, S. (1996). Sequential activation of ICE-like and CPP32-like proteases during Fasmediated apoptosis. Nature 380, 723-726.
21. Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middelton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J., and Puck, J.M. (1995). Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946.
22. Gajewski, T.F., and Thompson, C.B. (1996). Apoptosis meets signal transduction: elimination of BAD influence. Cell 87, 589-592.
23. Gamen, S., Marzo, I., Anel, A., Piñeiro, A., and Naval, J. (1996). CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells. FEBS Lett. 390, 233-237.
24. Gearing, A.J.H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A.M., Drummond, A.M., Galloway, W.A., Gilbert, R., Gordon, J.L., et al. (1994). Processing of tumor necrosis factor-α precursor by metalloproteinases. Nature 370, 555-557.
25. Grell, M., Douni, E., Wajant, H., Lop̈hden, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., and Scheurich, P. (1995). The transmembrane form of the tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83, 793-802.
26. Griffith, T.S., Brunner, T., Fletcher, S.M., Green, D.R., and Ferguson, T.A. (1995). Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192.
27. Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L.E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996). Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape. Science 274, 1363-1366.
28. Hengartner, M.O., and Horvitz, H.R. (1994). C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian protooncogene bcl-2. Cell 76, 665-676.
29. Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 495-504.
30. Hsu, H., Huang,J.,Shu, H.-B., Baichwal, V., and Goeddel, D. (1996a). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396.
31. Hsu, H., Shu, H.-B., Pan, M.-G., and Goeddel, D.V. (1996b). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transcription pathways. Cell 84, 299-308.
32. Huang, B., Eberstadt, M., Olejniczak, E.T., Meadows, R.P., and Fesik, S.W. (1996).NMR structure and mutagenesis of the Fas (Apo1/CD95) death domain. Nature 384, 638-641.
33. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
34. Itoh, N., and Nagata, S. (1993). A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J. Biol. Chem. 268, 10932-10937.
35. Itoh, N., Tsujimoto, Y., and Nagata, S. (1993). Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151, 621-627.
36. Jacobson, M.D., Weil, M., and Raff, M.C. (1997). Programmed cell death in animal development. Cell, this issue.
37. Jones, E.Y., Stuart, D.I., and Walker, N.P.C. (1989). Structure of tumour necrosis factor. Nature 338, 225-228.
38. Kischkel, F.C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P.H., and Peter, M.E. (1995). Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins from a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579-5588.
39. Kiston, J., Raven, T., Jiang, Y.-P., Goeddel, D.V., Giles, K.M., Pun, K.-T., Grinham, C.J., Brown, R., and Farrow, S.N. (1996). A deathdomain-containing receptor that mediates apoptosis. Nature 384, 372-375.
40. Knudson, C.M., Tung, K.S., Tourtellotte, W.G., Brown, G.A., and Korsmeyer, S.J. (1995). Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-99.
41. Krippner, A., Matsuno-Yagi, A., Gottlieb, R., and Babior, B. (1996). Loss of function of cytochrome c in Jurkat cells undergoing Fasmediated apoptosis. J. Biol. Chem. 271, 21629-21636.
42. Kuida, K., Zheng, T.S., Na, S.-Q., Kuan,C.-Y., Yang, D., Karasuyama, H., Rakic, P., and Flavell, R.A. (1996). Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368-372.
43. Lau,H.T., Yu, M., Fontana, A., and Stoeckert Jr., C.J. (1996). Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273, 109-112.
44. Lenczowski, J.M., Dominguez, L., Eder, A., King, L.B., Zacharchuk, C.M., and Ashwell, J.D. (1997). Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol. Cell. Biol. 17, 170-181.
45. Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., et al. (1995). Mice deficient in IL-1 β-Converting enzyme are defective in production of mature IL-1 β and resistant to endotoxic shock. Cell 80, 401-411.
46. Liu, Z.-G., Hsu, H., Goeddel, D., and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576.
47. Los, M., Van de Craen, M., Penning, L.C., Schenk, H., Westendorp, M., Baeuerle, P.A., Dröge, W., Krammer, P.M., Fiers, W., and Schulze-Osthoff, K. (1995). Requirement of an ICE/CED-3 protease for Fas/ APO-1-mediated apoptosis. Nature 375, 81-83.
48. Montogomery, R.I., Warner, M.S., Lum, B.J., and Spear, P.G. (1996). Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87, 427-436.
49. Motoyama, N., Wang, F., Roth, K.A., Sawa, H., Nakayama, K., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., and Loh, D.Y. (1995). Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267, 1506-1510.
50. Muchmore, S.W., Sattlet, M., Liang, H., Meadows, R.P., Harlan, J.E., Yoon, H.S., Nettesheim, D., Chang, B.S., Thompson, C.B., Wong, S.L., Ng, S.L., and Fesik, S.W. (1996). X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335-341.
51. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95(Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
52. Nagata, S., and Golstein, P. (1995). The Fas death factor. Science 267, 1449-1456.
53. Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazebnik, Y.A., et al. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
54. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., Trauth, B.C., et al. (1992). Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J. Biol. Chem. 267, 10709-10715.
55. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S. (1993). Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809.
56. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I.A., Debatin, K.M., Fischer, A., and de Villarty, J.P. (1995). Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349.
57. Rodriguez, I., Matsuura, K., Ody, C., Nagata, S., and Vassalli, P. (1996a). Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med., in press.
58. Rodriguez, I., Matsuura, K., Khatib, K., Reed, J.C., Nagata, S., and Vassalli, P. (1996b). A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J. Exp. Med. 183, 1031-1036.
59. Rothe, M., Wong, S.C., Henzel, W.J., and Goeddel, D.V. (1994). A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692.
60. Rothstein, T.L., Wang, J.K.M., Panka, D.J., Foote, L.C., Wang, Z., Stanger, B., Cui, H., Ju, S.-T., and Marshak-Rothstein, A. (1995). Protection against Fas-dependent Th1 -mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163-165.
61. Schulze-Osthoff, K., Walczak, H., Dröge, W., and Krammer, P.H. (1994). Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell Biol. 127, 15-20.
62. Shaham, S., and Horvitz, H.R. (1996). Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities. Genes Dev. 10, 578-591.
63. Singer, G.G., and Abbas, A.K. (1994). The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365-371.
64. Spiegel, S., Foster, D., and Kolesnick, R. (1996). Signal transduction through lipid second messengers. Curr. Opin. Cell Biol. 8, 159-167.
65. Strand, S., Hofmann, W.J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S.M., Stremmel, W., Krammer, P.H., and Galle, P.R. (1996). Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand expressing tumor cells - A mechanism of immune evasion. Nature Med. 2, 1361-1366.
66. Suda,T., Takahashi,T., Golstein, P., and Nagata, S. (1993). Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 75, 1169-1178.
67. Takahashi, A., Alnemli, E.S., Lazebnik, Y.A., Fernandes-Alnemri, T., Litwack, G., Moir, R.D., Goldman, R.D., Poirier, G.G., Kaufmann, S.H., and Earnshaw, W.C. (1996). Cleavage of lamin A by Mch2a but not CPP32: Multiple interleukin 1β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA 93, 8395-8400.
68. Takahashi, T., Tanaka, M. Brannan, C.I., Jenkins, N.A., Copeland, N.G., Suda, T. and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
69. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996). Fas ligand in human serum. Nature Med. 2, 317-322.
70. Tanaka, M., Suda, T., Yatomi, T., Nakamura, N., and Nagata, S. (1997). Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium Acnes. J. Immunol., in press.
71. Tartaglia, L.A., Ayres, T.M., Wong, G.H.W., and Goeddel, D.V. (1993). A novel domain within the 55 kd TNF receptor signals cell death. Cell 74, 845-853.
72. Tewari, M., and Dixit, V.M. (1995). Fas-and tumor necrosis factorinduced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270, 3255-3260.
73. Thornberry, N.A., Bull, H.G., Calaycay, J.R., Chapman, K.T., Howard, A. D., Kostura, M.J., Miller, D.K., Molineaux, S.M., Weidner, J.R., Aunins, J., et al. A novel heterodimeric cysteine protease is required for interleukin-1 β processing in monocytes. Nature 356, 768-774.
74. Trauth, B.C., Klas, C., Peters, A.M.J., Matzuku, S., Möller, P., Falk, W., Debatin, K.-M.,and Krammer, P.H. (1989). Monoclonal antibodymediated tumor regression by induction of apoptosis. Science 245, 301-305.
75. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R., and Verma, I.M. (1996). Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789.
76. Vandenabeele, P., Declercq, W., Beyaert, R., and Fiers, W. (1995). Two tumor necrosis factor receptors: structure and function. Trends Cell Biol 5, 392-399.
77. Veis, D.J.,Sorenson,C.M., Shutter, J.R., and Korsmeyer, S.J. (1993). Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-240.
78. Wang, C.-Y., Mayo, M.W., and Balwin Jr, A.S. (1996). TNF-and cancer therapy-induced apoptosis: potentiation byinhibition of NFκB. Science 274, 784-787.
79. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., and Nagata, S. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
80. Wu, J., Zhou, T., Zhang, J., He, J., Gause, W.C., and Mountz, J.D. (1994). Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc. Natl. Acad. Sci. USA 91, 2344-2348.
81. Yang, E., and Korsmeyer, S.J. (1996). Molecular thanatopsis: a discourse on the Bcl2 family and cell death. Blood 88, 386-401.
82. Yonehara, S., Ishii, A., and Yonehara, M. (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down regulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.
83. Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M., and Horvitz, H.R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 β-converting enzyme. Cell 75, 641-652.
84. Zamzami, N., Susin, S.A., Marchetti, P., Hirsch, T., Gómez-Monterrey, I., Castedo, M., and Kroemer, G. (1996). Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183, 1533-1544.
85. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S.J. (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not Bcl-x. Cell 87, 619-628.